Abstract
Human 5-HT1D/1B receptors are the likely therapeutic targets of several clinically used migraine-abortive triptans such as sumatriptan. The present investigation, using several QSAR methods (e.g. CoMFA and Hansch analysis), attempts to better explain the structure-affinity relationships of 2-(benzyl)imidazolines and benzylimidazoline-related compounds for binding at h5-HT1D receptors. It was found that lipophilicity at the 4-position of benzylimidazolines correlates well both with h5-HT1D and h5-HT1B receptor affinity.
Original language | English |
---|---|
Pages (from-to) | 309-317 |
Number of pages | 9 |
Journal | Medicinal Chemistry Research |
Volume | 10 |
Issue number | 5 |
State | Published - 2001 |
ASJC Scopus subject areas
- General Pharmacology, Toxicology and Pharmaceutics
- Organic Chemistry